McKesson Corporation vs Johnson & Johnson
MCK vs JNJ — side-by-side comparison from reported financials. MCK leads 7, JNJ leads 4 of 11 comparable metrics.
McKesson Corporation
MCK · Healthcare
$938.84+0.92%Solid
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
| Metric | MCK | JNJ |
|---|---|---|
| Price | $938.84 | $261.79 |
| Market cap | $109B | $631B |
| Revenue (TTM) | $411B | $97.9B |
| Revenue growth | +13.4% | +5.6% |
| Net margin | 1.1% | 21.5% |
| Free cash flow | $6.42B | $22.2B |
| Net cash (debt) | ($4.81B) | ($27.8B) |
| 1-year price return | +23.9% | +37.0% |
| P/E | 23.8 | 29.9 |
| P/E vs own history (cheap-side %) | 59% | 16% |
| Dividend yield | 0.36% | 2.00% |
| Return on equity | 39% | 26% |
| Altman Z-score | 2.25 | — |
| CV checks passed | 11 of 11 | 10 of 11 |
| Employees | 43,000 | 140,800 |
Full résumé-style profiles: MCK CV · JNJ CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.